Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal

Completed · Phase 4

Conditions studied: Alcohol Withdrawal

In brief

A randomized, double-blind controlled trial comparing treatment outcomes between chlordiazepoxide, or gabapentin to treat alcohol withdrawal syndrome in alcohol dependent veteran subjects. The objective of this trial is to compare the safety and effectiveness of these two medications. Intervention is a fixed dose taper of chlordiazepoxide, or gabapentin over 6 days. Subjects will be evaluated for 7-10 days to monitor alcohol abstinence, withdrawal severity scores, adverse events including ataxia, sedation, cognitive function and alcohol craving.

Key facts

Study ID

NCT01573052

Run by

VA Salt Lake City Health Care System

People needed

26

Starts

2004-03-01

Expected to finish

2010-09-01

Last updated by the study team

2020-08-17

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Alcohol dependent at risk for withdrawal symptoms

You may not qualify if…

• Benzodiazepine dependent

Where it is running

• George E Wahlen VA Medical Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.